CIRRX
Price
$17.51
Change
-$0.06 (-0.34%)
Updated
Oct 8 closing price
Net Assets
8.35B
FHEAX
Price
$16.42
Change
-$0.04 (-0.24%)
Updated
Oct 8 closing price
Net Assets
183.9M
Interact to see
Advertisement

CIRRX vs FHEAX

Header iconCIRRX vs FHEAX Comparison
Open Charts CIRRX vs FHEAXBanner chart's image
Cohen & Steers Real Estate Securities R
Price$17.51
Change-$0.06 (-0.34%)
VolumeN/A
Net Assets8.35B
Fidelity Advisor Real Estate A
Price$16.42
Change-$0.04 (-0.24%)
VolumeN/A
Net Assets183.9M
CIRRX vs FHEAX Comparison Chart in %
View a ticker or compare two or three
VS
CIRRX vs. FHEAX commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CIRRX is a Buy and FHEAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CIRRX has more cash in the bank: 8.35B vs. FHEAX (184M). CIRRX pays higher dividends than FHEAX: CIRRX (2.37) vs FHEAX (1.68). CIRRX was incepted earlier than FHEAX: CIRRX (11 years) vs FHEAX (23 years). CIRRX (1.25) is less costly to investors than FHEAX (1.03). CIRRX is a more actively managed with annual turnover of: 35.00 vs. FHEAX (24.00). CIRRX (0) and FHEAX (0) have matching initial minimum investment requirements. CIRRX annual gain was more profitable for investors over the last year : -2.00 vs. FHEAX (-8.53). CIRRX return over 5 years is better than : 26.81 vs. FHEAX (-11.08).
CIRRXFHEAXCIRRX / FHEAX
Total Expense Ratio1.251.03121%
Annual Report Gross Expense Ratio1.251.03121%
Fund Existence11 years23 years-
Gain YTD4.1881.270330%
Front LoadN/A6%-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets8.35B184M4,540%
Annual Yield % from dividends2.371.68141%
Returns for 1 year-2.00-8.5323%
Returns for 3 years32.192.741,176%
Returns for 5 years26.81-11.08-242%
Returns for 10 years54.80-14.06-390%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NECCX14.820.02
+0.14%
Natixis US Equity Opportunities C
JFNSX70.08N/A
N/A
Janus Henderson Global Life Sciences S
VMCPX396.31N/A
N/A
Vanguard Mid Cap Index InstitutionalPlus
BGLAX14.91N/A
N/A
Brookfield Global Listed InfrastructureA
BRWRX27.40N/A
N/A
MFS Blended Research Growth Eq R1